260 likes | 431 Views
Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy. Heart Failure Epidemiology (US Data). CHF Hospitalizations by Age, 2000 and 2010. Consequences of Heart Failure. Impact of Affordable Care Act on HF Readmission. Impact of Affordable Care Act on HF Readmission (cont).
E N D
Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy
The Importance of Serial NP Measurements for Prognostication in Chronic HF
PROTECT Study Primary End Point: Total Cardiovascular Events
PROTECT Secondary End Points: HF Hospitalization and Rehospitalization
Guided Therapy Combined AnalysesSuggest Benefit, All-Cause Mortality